Trials / Completed
CompletedNCT02336347
A Phase 1 Study Comparing AVP-786 With AVP-923
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, 2-way Crossover Study Comparing AVP-786 With AVP-923
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Avanir Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To compare pharmacokinetics (PK) of AVP-786 (deuterated \[d6\] dextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) to AVP-923 (dextromethorphan hydrobromide \[DM\]/Q) at steady state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AVP-786 | |
| DRUG | AVP-923 |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-09-01
- Completion
- 2015-03-01
- First posted
- 2015-01-13
- Last updated
- 2015-07-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02336347. Inclusion in this directory is not an endorsement.